ORIC · Categories · Form 4

ORIC - SEC Form 4 insider transactions

Oric Pharmaceuticals Inc. (ORIC) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ORIC

• 104d
  Chief Financial Officer Piscitelli Dominic exercised 52,000 shares at a strike of $4.36 and sold $702,686 worth of shares (52,000 units at $13.51) (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 141d
  Director Heyman Richard A. sold $80,431 worth of shares (6,700 units at $12.00), decreasing direct ownership by 8% to 41,800 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 155d
  SEC Form 4 filed by Director You Angie

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 155d
  SEC Form 4 filed by Director Kunkel Lori Anne

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 155d
  SEC Form 4 filed by Director Hoerter Steven L.

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 155d
  SEC Form 4 filed by Director Heyman Richard A.

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 155d
  SEC Form 4 filed by Director Dier Mardi

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 155d
  SEC Form 4 filed by Chief Financial Officer Piscitelli Dominic

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 155d
  SEC Form 4 filed by Chief Medical Officer Multani Pratik S

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 155d
  SEC Form 4 filed by PRESIDENT AND CEO Chacko Jacob

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 175d
  Chief Medical Officer Multani Pratik S sold $97,129 worth of shares (10,720 units at $9.06) and converted options into 29,333 shares, increasing direct ownership by 38% to 68,149 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 175d
  PRESIDENT AND CEO Chacko Jacob converted options into 83,666 shares and sold $302,368 worth of shares (33,374 units at $9.06), increasing direct ownership by 9% to 581,711 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 175d
  Chief Financial Officer Piscitelli Dominic converted options into 29,333 shares and sold $97,127 worth of shares (10,720 units at $9.06), increasing direct ownership by 38% to 68,148 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 183d
  Director Kunkel Lori Anne exercised 10,000 shares at a strike of $7.90, increasing direct ownership by 13% to 84,200 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 187d
  Director Kunkel Lori Anne exercised 5,534 shares at a strike of $3.75, increasing direct ownership by 8% to 74,200 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 245d
  Chief Financial Officer Piscitelli Dominic exercised 11,000 shares at a strike of $4.36 and sold $159,719 worth of shares (11,000 units at $14.52) (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 245d
  PRESIDENT AND CEO Chacko Jacob sold $461,520 worth of shares (37,461 units at $12.32), decreasing direct ownership by 7% to 531,419 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 250d
  Director Heyman Richard A. exercised 32,800 shares at a strike of $1.69, increasing direct ownership by 262% to 45,300 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 251d
  PRESIDENT AND CEO Chacko Jacob sold $1,053,555 worth of shares (87,539 units at $12.04), decreasing direct ownership by 13% to 568,880 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 259d
  PRESIDENT AND CEO Chacko Jacob sold $1,349,938 worth of shares (125,000 units at $10.80), decreasing direct ownership by 16% to 656,419 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 343d
  Chief Financial Officer Piscitelli Dominic sold $200,972 worth of shares (20,000 units at $10.05), decreasing direct ownership by 29% to 48,317 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 351d
  Chief Financial Officer Piscitelli Dominic sold $351,384 worth of shares (33,500 units at $10.49), decreasing direct ownership by 33% to 68,317 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 362d
  Chief Financial Officer Piscitelli Dominic sold $3,000 worth of shares (300 units at $10.00), decreasing direct ownership by 0.29% to 101,817 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 364d
  Chief Financial Officer Piscitelli Dominic sold $33,017 worth of shares (3,300 units at $10.01), decreasing direct ownership by 3% to 102,117 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 366d
  Chief Financial Officer Piscitelli Dominic sold $29,021 worth of shares (2,900 units at $10.01), decreasing direct ownership by 3% to 103,864 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 463d
  Director Kunkel Lori Anne exercised 48,166 shares at a strike of $4.85, increasing direct ownership by 235% to 68,666 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 520d
  SEC Form 4 filed by Director You Angie

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 520d
  SEC Form 4 filed by Director Kunkel Lori Anne

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 520d
  SEC Form 4 filed by Director Hoerter Steven L.

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 520d
  SEC Form 4 filed by Director Heyman Richard A.

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 520d
  SEC Form 4 filed by Director Dier Mardi

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 523d
  SEC Form 4 filed by Chief Medical Officer Multani Pratik S

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 523d
  SEC Form 4 filed by Chief Financial Officer Piscitelli Dominic

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 523d
  SEC Form 4 filed by PRESIDENT AND CEO Chacko Jacob

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 540d
  Chief Financial Officer Piscitelli Dominic converted options into 24,042 shares and sold $73,298 worth of shares (8,851 units at $8.28), increasing direct ownership by 17% to 106,764 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 540d
  Chief Medical Officer Multani Pratik S converted options into 24,042 shares and sold $73,293 worth of shares (8,850 units at $8.28), increasing direct ownership by 48% to 46,765 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 540d
  PRESIDENT AND CEO Chacko Jacob converted options into 67,000 shares and sold $204,214 worth of shares (24,660 units at $8.28), increasing direct ownership by 6% to 778,648 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 726d
  SEC Form 4 filed by Director You Angie

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 726d
  SEC Form 4 filed by Director Kunkel Lori Anne

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 726d
  SEC Form 4 filed by Director Hoerter Steven L.

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 726d
  SEC Form 4 filed by Director Dier Mardi

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 726d
  SEC Form 4 filed by Director Heyman Richard A.

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 736d
  Kunkel Lori Anne exercised 20,500 shares at a strike of $3.75 (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 824d
  Chacko Jacob sold $648,380 worth of shares (40,000 units at $16.21), decreasing direct ownership by 5% to 728,544 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 853d
  Chacko Jacob sold $489,346 worth of shares (40,000 units at $12.23), decreasing direct ownership by 5% to 768,544 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 889d
  SEC Form 4 filed by Multani Pratik S

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 889d
  SEC Form 4 filed by Piscitelli Dominic

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 889d
  SEC Form 4 filed by Chacko Jacob

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 904d
  Multani Pratik S sold $45,351 worth of shares (5,282 units at $8.59) and converted options into 14,042 shares, increasing direct ownership by 58% to 23,809 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 904d
  Piscitelli Dominic sold $45,338 worth of shares (5,282 units at $8.58), decreasing direct ownership by 19% to 83,809 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 904d
  Chacko Jacob converted options into 38,667 shares and sold $124,813 worth of shares (14,539 units at $8.58), increasing direct ownership by 3% to 808,544 units (SEC Form 4)

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 1065d
  SEC Form 4 filed by Chacko Jacob

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 1069d
  SEC Form 4 filed by Chacko Jacob

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 1078d
  SEC Form 4 filed by Chacko Jacob

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 1091d
  SEC Form 4 filed by You Angie

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 1091d
  SEC Form 4 filed by Kunkel Lori Anne

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 1091d
  SEC Form 4 filed by Hoerter Steven L.

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 1091d
  SEC Form 4 filed by Heyman Richard A.

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 1091d
  SEC Form 4 filed by Dier Mardi

  4 - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)
• 1209d
  SEC Form 4: Multani Pratik S sold $6,846 worth of shares (2,227 units at $3.07), decreasing direct ownership by 23% to 7,285 units (for withholding tax) (Amendment)

  4/A - Oric Pharmaceuticals, Inc. (0001796280) (Issuer)

Other ORIC categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends